CliniGA CRO

CliniGA CRO Blog

Linking IVD interference planning to use context

Select possible interferents through the assay claim and specimen conditions rather than a copied list.

Representative research photograph: Linking IVD interference planning to use context
Photo: NASA · License: Public domain · Cropped and resized.
Published
Updated

An IVD interference question asks whether an unwanted influence changes measurement or interpretation. One standard list for every method may omit important questions. Justify scope against technology, specimen and intended population.

Define the assessment

Define why an influence matters, the condition represented and the assessment approach. A general technical experiment does not automatically cover every clinical specimen. Presence of the influence, measurement change and effect on the decision category may provide different information, with distinct limitations.

Worked example

For example, an assay study initially examines a specimen characteristic only at high analyte levels. The team considers whether this answers the question near the decision boundary. It explains how prepared experimental material differs from real clinical specimens and avoids claiming no effect under every untested condition.

Practical checks

  • Connect influence selection to the method, specimen and clinical-use rationale.
  • Preserve comparability and preparation traceability of control and challenged specimens.
  • Assess measurement differences separately from changes in clinical decision category.

Decision and limitations

Acceptance should explain what the tested condition establishes and what remains uncovered. One favourable experiment does not close every interference possibility. Qualified technical and clinical reviewers assess implications for instructions, risk or further evidence, without inventing universal thresholds or sample counts.

Frequently asked questions

Does the same interferent list fit every test?
No. Justify relevance to the method, specimen and use context.
Does no detected effect cover every condition?
Interpret only within the investigated scope and disclose unrepresented conditions.

Sources

  1. MDCG 2022-2 — IVD clinical evidence principles
  2. MDCG 2025-5 — IVD performance studies